Merrill

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas

Edward S. Kim, J. Lee, A. Tsao, 2018, The oncologist.